Making remote blood pressure monitoring work in pregnancy

The cost-effectiveness of remote monitoring for hypertension in pregnancy depends on more than the price of a blood pressure cuff. It rests on whether home readings identify deterioration early, reduce unnecessary hospital visits, support timely treatment and prevent serious complications such as pre-eclampsia, stroke, early birth or admission to intensive care.

For Australian maternity services, telemonitoring can shift some care from hospital clinics to the home. A pregnant woman records her blood pressure and symptoms, with results reviewed through a secure platform and escalated according to an agreed clinical protocol. The model may be especially useful when frequent appointments are difficult because of distance, work, transport, childcare or limited specialist availability.

Economic value is therefore measured across the whole care pathway. A service must account for devices, software, onboarding, data review, clinical escalation, training and technical support, then set these costs against avoided appointments, ambulance transfers, emergency presentations, inpatient days and adverse maternal or neonatal outcomes.

The strongest local decisions will combine economic evidence with clinical experience and community needs. Collaborative groups such as the health translation network can help connect researchers, universities, clinicians and health services so that promising digital care is tested in practice rather than assessed only in theory.

How remote monitoring changes maternity care

Standard hypertension management may involve repeated outpatient appointments, pathology, fetal surveillance and occasional hospital observation. These contacts are clinically important, but some visits result in reassurance rather than a change in treatment. Home blood pressure monitoring can provide more frequent information between appointments and help clinicians focus resources on people whose readings or symptoms are changing.

A digital pathway usually includes a validated cuff, patient education, scheduled measurements and a response system. Readings might be reviewed daily or on set weekdays, with red flags such as severe hypertension, headache, visual disturbance or upper abdominal pain prompting immediate assessment. The value comes from the complete pathway, not from the device alone.

Where the economic benefits may arise

The clearest potential saving is fewer avoidable face-to-face contacts. For a woman living in regional Queensland, avoiding several trips to a tertiary maternity service can reduce travel reimbursement, parking, time away from work and pressure on family members. For a hospital, fewer low-risk reviews may release clinic capacity for complex cases.

Earlier recognition may also prevent costly escalation. Severe hypertension and pre-eclampsia can lead to emergency assessment, admission, early delivery and neonatal care. Remote monitoring cannot eliminate these events, and it must never delay urgent review, but timely escalation may shorten the interval between deterioration and treatment. An economic evaluation should include both costs avoided and health outcomes gained.

What matters in the Australian setting

Australia’s geography makes the service design particularly important. Someone in Brisbane may live close to a maternity assessment unit, while a family in western Queensland may face hours on the road or a flight to reach specialist care. In Far North Queensland and other remote areas, unreliable internet, limited local pathology and workforce shortages can affect whether a digital pathway is safe and practical.

The public and private systems also have different workflows and funding arrangements. Queensland Health services may need to integrate remote readings with existing hospital records, escalation policies and statewide governance requirements. Private obstetric practices may use different platforms and staffing models. Costs that sit outside routine Medicare activity, such as data review or after-hours response, should be made visible rather than assumed to be absorbed.

Language and culture matter as much as connectivity. Aboriginal and Torres Strait Islander families may prefer care that involves local health workers, culturally safe communication and trusted community-controlled services. A service that offers only an English-language app and assumes private smartphone access may produce poor uptake and widen inequity.

What the evidence needs to measure

Clinical trials and service evaluations should report more than average blood pressure. Important outcomes include severe hypertension, pre-eclampsia, emergency presentations, hospital admissions, planned and unplanned births, gestational age at delivery, neonatal intensive care, maternal readmissions and patient-reported confidence.

The economic analysis should use a health-system perspective and, where possible, a broader societal perspective. Costs can include equipment, platform licences, staff training, midwife or obstetrician review time, technical support and replacement devices. Broader analysis can add travel, lost earnings, accommodation and unpaid carer time. Quality-adjusted life years may be useful, but pregnancy-specific outcomes and family impact should remain prominent.

A short pilot can reveal operational problems that a formal trial misses. For example, clinicians may receive readings without enough context, patients may upload data irregularly, or alerts may create extra workload. Measuring alert volume, response times and staff time helps establish whether the pathway is genuinely efficient.

Designing for safety and equity

Home monitoring should complement, rather than replace, clinical judgement. Every participant needs clear written and verbal instructions about cuff position, measurement technique and symptoms requiring urgent help. A reading above the local escalation threshold should not sit in an inbox waiting for the next routine review.

Digital inclusion should be built into the budget. Some families will need a loan device, mobile data, translated resources, an interpreter, telephone support or assistance from a community midwife. A telephone-based alternative can be safer than excluding people who lack a compatible phone or stable broadband.

Privacy and governance also carry costs. Platforms must manage identifiable health information securely, define who can access readings and record actions taken in response to alerts. Procurement should assess interoperability with clinical records and the practical requirements of Queensland health services, rather than selecting a product on the basis of dashboard features alone.

Understanding value for women and services

Patient experience is a central economic consideration. Remote care may reduce long journeys and waiting-room time, but frequent monitoring can also create anxiety or make women feel responsible for detecting a medical emergency. Surveys and interviews should examine convenience, confidence, burden, trust and whether people feel connected to their care team.

Clinician experience is equally relevant. If remote monitoring adds unplanned work without reducing clinic activity, its cost-effectiveness will be weak even when patient satisfaction is high. Clear rosters, escalation rules and protected review time can make the difference between a sustainable service and a temporary project.

Researchers should compare results across metropolitan, regional, rural and remote settings. A model that is cost-saving in inner Brisbane may require extra investment in Mount Isa or the Torres Strait, yet still be worthwhile because it improves access and reduces the need for long-distance transfers. Equity-adjusted decisions can recognise these benefits rather than treating every location as if it had the same baseline costs.

Comparing care models and funding choices

There is no single best model for every maternity service. Some programs use loaned devices with clinician-led review, while others ask women to purchase a validated cuff and report readings through an app or telephone line. The appropriate choice depends on risk level, digital access, local workforce and the ability to provide urgent assessment.

A business case should show start-up and recurring costs separately. It should also state who pays for the platform, devices, staff time, training and replacement equipment. Linking economic findings to implementation research and clinical governance can help Australian services move from a promising pilot to a dependable part of antenatal care.

Health services, researchers and maternity clinicians can build a stronger case by collecting local costs alongside maternal and neonatal outcomes. Evaluating remote blood pressure monitoring through real-world partnerships will help identify where it delivers genuine value, where safeguards need strengthening and how Australian families can receive safer, more accessible pregnancy care.